Neha Krishnamohan

Board Member

Neha Krishnamohan joined our board of directors in September 2022. Ms Krishnamohan is currently the chief financial officer and executive vice president of corporate development at Artiva Biotherapeutics, with over 15 years of experience in healthcare investment banking, financial and strategic leadership. She was most recently the Chief Financial Officer and Executive Vice President, Corporate Development at Kinnate Biopharma Inc., a clinical stage precision oncology company where she led the company’s financial operations, business development, and investor relations / communications functions. Ms Krishnamohan was also a leader on Kinnate’s exploration of strategic alternatives, which resulted in a successful asset sale to Pierre Fabre Laboratories and the sale of Kinnate to XOMA Corporation. Prior to Kinnate, Ms Krishnamohan was a vice president in the Healthcare Investment Banking Group and a member of the Mergers and Acquisitions (M&A) Group within the Investment Banking Division at Goldman Sachs. While at Goldman Sachs, she established herself as a senior leader in the healthcare coverage group, working with a variety of biopharmaceutical boards and management teams on a broad range of strategic financial matters, executing financings as well as leading M&A transactions. Of note, she was one of the lead bankers on Arcutis’ highly successful 2020 initial public offering. Ms Krishnamohan has successfully executed over $100 billion in transactions in the biopharmaceutical, medical technology, and tools/diagnostics sectors. Ms Krishnamohan holds a BSE with a double major in Biomedical Engineering and Economics from Duke University.